Investigating Potential Cancer Therapeutics: Insight into Histone Deacetylases (HDACs) Inhibitions

• Prif Awduron: Basharat Ahmad (Awdur), Aamir Saeed (Awdur), Ahmed Al-Amery (Awdur), Ismail Celik (Awdur), Iraj Ahmed (Awdur), Muhammad Yaseen (Awdur), Imran Ahmad Khan (Awdur), Dhurgham Al-Fahad (Awdur), Mashooq Ahmad Bhat (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2024-03-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Histone deacetylases (HDACs) are enzymes that remove acetyl groups from ɛ-amino of histone, and their involvement in the development and progression of cancer disorders makes them an interesting therapeutic target. This study seeks to discover new inhibitors that selectively inhibit HDAC enzymes whi...